Does LEVOMILNACIPRAN Cause Therapeutic product effect incomplete? 134 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Therapeutic product effect incomplete have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 9.7% of all adverse event reports for LEVOMILNACIPRAN.
134
Reports of Therapeutic product effect incomplete with LEVOMILNACIPRAN
9.7%
of all LEVOMILNACIPRAN reports
133
Deaths
93
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From LEVOMILNACIPRAN?
Of the 134 reports, 133 (99.3%) resulted in death, 93 (69.4%) required hospitalization, and 94 (70.1%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which LEVOMILNACIPRAN Alternatives Have Lower Therapeutic product effect incomplete Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE